Goal setting in rehabilitation can be particularly difficult. Clients understandably want to know: “How soon can I see the benefits of a particular intervention?” The benefit can be perceived in two ways: the extent of relief provided and the duration of the relief.

As a product and service provider, it's important to us that we manage expectations. That we don't over-promise and under-deliver, and for that reason, we work with medical devices that have at least some research guidance on expected results. Even in the best cases, there will there be individual variations in how someone responds to an intervention.

Transcutaneous spinal cord stimulation (tSCS) represents a promising noninvasive neuromodulation technique for rehabilitation in spinal cord injury (SCI) and other neurological conditions such as multiple sclerosis (MS).

This article examines three distinct therapeutic applications—spasticity, pain, and functional recovery—each with different treatment requirements and expected outcomes. In basic terms, we review how long treatment should last before beneficial effects emerge and, once they do, how long they will last.

Spasticity is common after spinal cord injury, and while medication can help, it isn’t always the best or only option. This article explores alternative ways to manage spasticity when medication isn’t effective or suitable. It looks at why symptoms can vary, what triggers may make spasticity worse, and the importance of an individualised approach. From rehabilitation strategies to practical day-to-day management, it provides a helpful overview for improving comfort, function, and quality of life.